Fusobacterium nucleatum的致癌和药物输送干预措施
1Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, NC 27599, United States.
Advanced drug delivery reviews
|April 21, 2024
概括
瘤微生物群,特别是Fusobacterium nucleatum,影响癌症的生长和治疗. 向F. nucleatum可能会激活对癌细胞的免疫反应,有助于疫苗的开发.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微生物组越来越被认为是癌症发展和治疗结果的关键因素.
- 菌核酸菌 (F. nucleatum) 涉及多种癌症类型,包括乳腺癌,结肠直肠癌和肺癌.
- 与瘤相关的微生物群落特定于癌症类型,并影响瘤微环境.
研究的目的:
- 综合审查微生物群落,特别是F.核在瘤组织中的作用.
- 探索这些微生物影响瘤启动,进展和治疗反应的机制.
- 讨论潜在的治疗策略,包括针对瘤相关细菌的疫苗开发.
主要方法:
- 对研究瘤微生物组和F. nucleatum.研究的文献综述.
- 对微生物对癌症影响的机械学数据的分析.
- 探索宿主对瘤相关细菌的免疫反应.
主要成果:
- 核菌在各种瘤中普遍存在,并影响癌症的进展.
- 与瘤相关的微生物群直接影响瘤的启动,生长和对化疗和免疫疗法等疗法的反应.
- 消除与瘤相关的F. nucleatum可以触发宿主对癌细胞的免疫反应.
结论:
- 瘤微生物组,特别是F.核,在癌症中发挥着关键作用.
- 了解这些微生物的作用可以导致新的治疗策略.
- 来自F. nucleatum的细菌表位对开发抗癌疫苗具有前途.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


